Total Payments
$29,352
2024 Payments
$14,445
Companies
38
Transactions
549
Medicare Patients
21,741
Medicare Billing
$3.7M
Payment Breakdown by Category
Other$10,650 (36.3%)
Food & Beverage$9,132 (31.1%)
Education$6,210 (21.2%)
Travel$3,359 (11.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,650 | 5 | 36.3% |
| Food and Beverage | $9,132 | 515 | 31.1% |
| Education | $6,210 | 15 | 21.2% |
| Travel and Lodging | $3,359 | 14 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13,831 | 111 | $0 (2024) |
| Intuitive Surgical, Inc. | $8,476 | 19 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,485 | 113 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,141 | 82 | $0 (2024) |
| Insmed, Inc. | $682.51 | 40 | $0 (2024) |
| GENZYME CORPORATION | $418.66 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $408.35 | 23 | $0 (2024) |
| Mylan Specialty L.P. | $297.50 | 16 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $297.49 | 10 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $274.62 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,445 | 130 | AstraZeneca Pharmaceuticals LP ($12,528) |
| 2023 | $8,710 | 121 | Intuitive Surgical, Inc. ($6,671) |
| 2022 | $2,957 | 86 | Intuitive Surgical, Inc. ($1,805) |
| 2021 | $914.00 | 58 | AstraZeneca Pharmaceuticals LP ($197.34) |
| 2020 | $1,055 | 73 | AstraZeneca Pharmaceuticals LP ($324.69) |
| 2019 | $755.27 | 46 | Pulmonx Corporation ($126.03) |
| 2018 | $468.02 | 33 | Philips Electronics North America Corporation ($149.34) |
| 2017 | $47.84 | 2 | United Therapeutics Corporation ($36.14) |
All Payment Transactions
549 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Medical Device | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Respiratory | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $129.02 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $57.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,200 | 10,078 | $2.1M | $823,004 |
| 2022 | 26 | 5,957 | 11,695 | $2.7M | $1.0M |
| 2021 | 35 | 5,802 | 10,807 | $2.6M | $970,772 |
| 2020 | 33 | 4,782 | 10,049 | $2.3M | $841,244 |
Total Patients
21,741
Total Services
42,629
Medicare Billing
$3.7M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 562 | 3,282 | $636,708 | $292,571 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 732 | 1,220 | $280,420 | $158,500 | 56.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 581 | 721 | $267,491 | $91,632 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 587 | 838 | $125,700 | $74,528 | 59.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 149 | 783 | $117,450 | $21,949 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 188 | 188 | $65,800 | $21,141 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 345 | $51,750 | $20,478 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 267 | 324 | $46,008 | $19,041 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 34 | 120 | $58,800 | $18,891 | 32.1% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 141 | 163 | $40,750 | $16,351 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 125 | 160 | $36,800 | $16,307 | 44.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 89 | 91 | $25,025 | $11,312 | 45.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 92 | 179 | $62,650 | $9,389 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 103 | 127 | $19,050 | $8,584 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 79 | 79 | $27,650 | $6,889 | 24.9% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 27 | 27 | $11,340 | $3,270 | 28.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 200 | 226 | $86,332 | $3,045 | 3.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $10,000 | $2,908 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,500 | $2,748 | 61.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 253 | 259 | $12,950 | $2,256 | 17.4% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 13 | 14 | $8,400 | $2,178 | 25.9% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 12 | 12 | $9,600 | $2,146 | 22.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 99 | 157 | $8,990 | $2,142 | 23.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 29 | 29 | $7,250 | $2,036 | 28.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 254 | 260 | $19,500 | $1,928 | 9.9% |
About Dr. Azmi Draw, MD
Dr. Azmi Draw, MD is a Pulmonary Disease healthcare provider based in Prospect, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801878806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Azmi Draw, MD has received a total of $29,352 in payments from pharmaceutical and medical device companies, with $14,445 received in 2024. These payments were reported across 549 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,650).
As a Medicare-enrolled provider, Draw has provided services to 21,741 Medicare beneficiaries, totaling 42,629 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Prospect, KY
- Active Since 11/16/2005
- Last Updated 01/19/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801878806
Products in Payments
- BREZTRI (Drug) $12,429
- Da Vinci Surgical System (Device) $5,476
- ION (Device) $3,000
- TRELEGY ELLIPTA (Drug) $834.08
- DUPIXENT (Biological) $716.15
- Arikayce (Drug) $666.27
- STIOLTO RESPIMAT (Drug) $608.42
- GLASSIA (Biological) $420.05
- OFEV (Drug) $402.10
- FASENRA (Biological) $394.64
- SYMBICORT (Drug) $374.60
- NUCALA (Biological) $317.21
- TEZSPIRE (Biological) $298.85
- AIRSUPRA (Drug) $273.28
- OPSUMIT (Drug) $200.46
- Yupelri (Drug) $191.70
- AREXVY (Drug) $157.54
- LONHALA MAGNAIR (Drug) $156.16
- WAKIX (Drug) $137.25
- ANORO (Drug) $129.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.